Nalorphine

Nalorphine

Gene therapy
Clinical data
Other names	(−)−(5R,6S)-9α-allyl- 4,5-epoxymorphin- 7-en- 3,6-diol
AHFS/Drugs.com	International Drug Names
ATC code	V03AB02 (WHO)
Physiological data
Legal status
Legal status	AU: S4 (Prescription only)
Pharmacokinetic data
Identifiers
IUPAC name (5α,6α)-17-allyl- 7,8-didehydro- 4,5-epoxymorphinan- 3,6-diol
CAS Number	62-67-9 Y
PubChem Template:Abbreviation	5284595
IUPHAR/BPS	1629
ChemSpider	4447643 Y
UNII	U59WB2WRY2
ChEMBL	ChEMBL415284 N
Chemical and physical data
Formula	C19H21NO3
Molar mass	311.375 g/mol
3D model (JSmol)	Interactive image
SMILES O[C@H]2\C=C/[C@H]5[C@@H]4N(CC[C@@]51c3c(O[C@H]12)c(O)ccc3C4)C\C=C
InChI InChI=1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1 Y Key:UIQMVEYFGZJHCZ-SSTWWWIQSA-N Y
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Nalorphine
Articles
Most recent articles on Nalorphine Most cited articles on Nalorphine Review articles on Nalorphine Articles on Nalorphine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nalorphine Images of Nalorphine Photos of Nalorphine Podcasts & MP3s on Nalorphine Videos on Nalorphine
Evidence Based Medicine
Cochrane Collaboration on Nalorphine Bandolier on Nalorphine TRIP on Nalorphine
Clinical Trials
Ongoing Trials on Nalorphine at Clinical Trials.gov Trial results on Nalorphine Clinical Trials on Nalorphine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nalorphine NICE Guidance on Nalorphine NHS PRODIGY Guidance FDA on Nalorphine CDC on Nalorphine
Books
Books on Nalorphine
News
Nalorphine in the news Be alerted to news on Nalorphine News trends on Nalorphine
Commentary
Blogs on Nalorphine
Definitions
Definitions of Nalorphine
Patient Resources / Community
Patient resources on Nalorphine Discussion groups on Nalorphine Patient Handouts on Nalorphine Directions to Hospitals Treating Nalorphine Risk calculators and risk factors for Nalorphine
Healthcare Provider Resources
Symptoms of Nalorphine Causes & Risk Factors for Nalorphine Diagnostic studies for Nalorphine Treatment of Nalorphine
Continuing Medical Education (CME)
CME Programs on Nalorphine
International
Nalorphine en Espanol Nalorphine en Francais
Business
Nalorphine in the Marketplace Patents on Nalorphine
Experimental / Informatics
List of terms related to Nalorphine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Nalorphine (INN; Lethidrone, Nalline), also known as N-allyl-normorphine, is a mixed opioid agonist–antagonist. It acts at two opioid receptors, at the mu receptor it has antagonistic effects and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence.

Synthesis

Nalorphine synthesis:

More recently, it has become much more commonplace to use ethyl chloroformate instead of cyanogen bromide for the Von Braun degradation demethylation step. See for example the list of phenyltropanes or the synthesis of paroxetine for further examples of this.